DWP-708

N/A

Report date: 2022/11/07 18:40:46

Base Information

Drug NameDWP-708
Drug Alias NameDWP-708
ClassificationBiologics
Mechanisms of ActionEpidermal growth factor receptor erbB1 antagonists
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsAcneiform Eruptions
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesDaewoong Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDaewoong Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsAcneiform Eruptions
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A